Search clinical trials for: NOMAC-E2

Total 213 results

Organon and Co

Completed

Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)

Healthy Postmenopausal Females
Center for Epidemiology and Health Research, Germany
Merck Sharp & Dohme LLC; Theramex

Completed

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg) (PRO-E2)

Contraception

Germany
Organon and Co
CRS Mannheim GmbH

Completed

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

Healthy
Organon and Co

Completed

Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

Contraception
Organon and Co

Completed

Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

Contraception
Organon and Co

Completed

Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)

Contraception
Organon and Co
IQVIA Inc.; OSTAtistics

Terminated

Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

Contraception

United States
Organon and Co

Completed

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

Contraception
Organon and Co

Withdrawn

Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)

Contraception
Organon and Co

Completed

Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)

Contraception
Organon and Co

Terminated

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

Contraception
Organon and Co

Completed

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

Contraception
Mansoura University

Completed

Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy

Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy
Theramex

Completed

Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol

Suppression of Ovulation
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

Suppression of Ovulation

United States
Genexine, Inc.

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects (GX-E2-P1)

Healthy

Korea, Republic of
Bayer

Completed

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (JULINA-CLIMA)

Osteoporosis, Postmenopausal

Japan
Bayer

Completed

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Osteoporosis, Postmenopausal

Japan
CytoCore, Inc.
University Hospitals Cleveland Medical Center

Completed

Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.

Colposcopy | Biopsy

United States
National Institute of Dental and Craniofacial Research...

Completed

Celebrex for Pain Relief After Oral Surgery

Facial Pain

United States
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
Akdeniz University

Completed

The Impact of Estrogen Administration Duration in Hormonally Prepared Frozen Embryo Transfer Cycles

Duration of Estrogen Administration

Turkey
AbbVie

Active, not recruiting

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Puerto Rico
Isala
Merck Serono International SA

Unknown

Predicting Ovarian Response in Artificial Insemination With Low Stimulation

Subfertility

Netherlands
Instituto de Cardiologia do Rio Grande do Sul

Completed

Polyphenols Supplementation on Prostaglandin E2 in Women - Randomized Clinical Trial

Inflammatory Disorder of the Cardiovascular System
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
University Medical Centre Maribor

Not yet recruiting

Propess Versus Prostin for Induction of Labour in Women With Term PROM (PESTIBOR)

Induction of Labour | Premature Rupture of Membranes at Term
Università degli Studi di Brescia

Completed

NSAIDs and PGE2 Levels in Vitrectomy Patients

Vitreous Inflammation
Organon and Co

Completed

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

Contraception
Boston Pharmaceuticals

Completed

Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects

Healthy Participants

United Kingdom
Oregon Health and Science University
Society of Family Planning

Completed

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

Ovulation (Follicular Rupture Yes/no) | Menstrual Cycles (Total Length, Bleeding Days) | Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)

United States
Rennes University Hospital
Institut National de la Recherche Agronomique

Completed

NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index. (NOMAC)

Healthy

France
Steven M Rowe

Completed

G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) (GOAL- e2)

Cystic Fibrosis

United States
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
Hanoi Obstetrics and Gynecology Hospital
Mỹ Đức Hospital

Recruiting

DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies (DOBA-PRO)

Induction of Labor

Vietnam
Instituto de Cardiologia do Rio Grande do Sul

Completed

Increase of Prostaglandin E2 in Reversal of Ductal Constriction After Dietary Restriction of Polyphenols

Pregnancy Complications
National Institute of Allergy and Infectious Diseases...

Completed

Chiron Corp HCV E1/E2 Vaccine

Hepatitis C

United States
Nanjing University

Unknown

GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

Infertile High-risk Patients With Polycystic Ovaries

China
Shanghai First Maternity and Infant Hospital

Unknown

The Use of High-energy Digestible Food in Women Undergoing Caesarean Section

Caesarean Section

China
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Unknown

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Female Contraception | Healthy Women

United States
Bio Genuine (Shanghai) Biotech Co., Ltd.

Recruiting

Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis

Endometriosis | Moderate to Severe Endometriosis-associated Pain

China
Bayer

Completed

Effects of Wellnara on Climacteric Symptoms

Postmenopause

Germany
Army Health Branch, British Army
University of East Anglia, Norwich, United Kingdom; Osteolabs, Kiel, Germany; University of Salford, Salford, United Kingdom and other collaborators

Recruiting

Effect of Oestrogen on Musculoskeletal Outcomes (E2)

Contraception | Estrogen Deficiency | Estrogen Excess

United Kingdom
Emory University

Withdrawn

Pilot E2 for Hypogonadal Women With CFBD

Cystic Fibrosis Related Bone Disease

United States
Troels Wienecke

Completed

Prostaglandin E2 in Migraine Suffers Without Aura.

"Migraine-like" Headache

Denmark
Population Council

Completed

A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women

Ovulation

Dominican Republic, Chile, United States
Bayer

Completed

ZK283197 for Treatment of Vasomotor Symptoms

Vasomotor System

Germany, Netherlands, United Kingdom
Mayo Clinic

Completed

Impact of Endogenous E2 on SSI and GH Rebound

Normal Healthy Volunteers

United States
Sydney Centre for Reproductive Health Research
Merck Sharp & Dohme LLC

Unknown

A New Treatment Option for Heavy Menstrual Bleeding

Menorrhagia

Australia
University of Michigan
National Institute on Aging (NIA)

Completed

Early Menopause Hormone Treatment and Cognition (R21)

Menopausal Syndrome

United States

3

Subscribe